Literature DB >> 3777042

Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis.

B M Sibai, A el-Nazer, A Gonzalez-Ruiz.   

Abstract

The purpose of this report is to compare subsequent pregnancy outcome and incidence of chronic hypertension and diabetes on follow-up in two groups of patients. Group 1 included 406 young women who had severe preeclampsia-eclampsia in their first pregnancies. Group 2 consisted of 409 young, well-matched women who remained normotensive during their first pregnancies. All patients were followed up for a minimum of 2 years (range 2 to 24). The preeclamptic-eclamptic group had a higher incidence of preeclampsia in their second pregnancies (46.8% versus 7.6%, p less than 0.0001) and in subsequent pregnancies (20.7% versus 7.7%, p less than 0.001) when compared with the normotensive group. The overall incidence of chronic hypertension was significantly higher in the preeclamptic-eclamptic group (14.8% versus 5.6%, p less than 0.001). Most of the difference occurred in patients followed up greater than or equal to 10 years. Within the preeclamptic-eclamptic group, patients having preeclampsia-eclampsia at less than or equal to 30 weeks' gestation and those having recurrent preeclampsia in their second pregnancies had a significantly higher incidence of subsequent chronic hypertension (p less than 0.001) than was found in the other patients. Within the normotensive group, patients remaining normotensive in subsequent pregnancies had the lowest incidence of chronic hypertension.

Entities:  

Mesh:

Year:  1986        PMID: 3777042     DOI: 10.1016/0002-9378(86)90336-4

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  56 in total

Review 1.  Pathophysiology and maternal biologic markers of preeclampsia.

Authors:  Jacques Massé; Yves Giguère; Abdelaziz Kharfi; Joël Girouard; Jean-Claude Forest
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

Review 2.  Role of placenta in preeclampsia.

Authors:  Leslie Myatt
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

Review 3.  Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?

Authors:  Naveed Sattar; Ian A Greer
Journal:  BMJ       Date:  2002-07-20

Review 4.  Hypertension in pregnancy.

Authors:  Maryann Mugo; Gurushankar Govindarajan; L Romayne Kurukulasuriya; James R Sowers; Samy I McFarlane
Journal:  Curr Hypertens Rep       Date:  2005-10       Impact factor: 5.369

Review 5.  Animal models of preeclampsia.

Authors:  Eduardo Podjarny; Gyorgy Losonczy; Chris Baylis
Journal:  Semin Nephrol       Date:  2004-11       Impact factor: 5.299

6.  Hypertensive Disorders of Pregnancy - A Life-Long Risk?!

Authors:  C E Schausberger; V R Jacobs; G Bogner; P Wolfrum-Ristau; T Fischer
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-01       Impact factor: 2.915

7.  Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013).

Authors:  H Stepan; S Kuse-Föhl; W Klockenbusch; W Rath; B Schauf; T Walther; D Schlembach
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-09       Impact factor: 2.915

8.  Risk for Recurrence of Pre-eclampsia in the Subsequent Pregnancy.

Authors:  Tarakeswari Surapaneni; Vidyavati Patil Bada; C Praveen Kumar Nirmalan
Journal:  J Clin Diagn Res       Date:  2013-12-15

9.  Impact of pregnancy-induced hypertension on stillbirth and neonatal mortality.

Authors:  Cande V Ananth; Olga Basso
Journal:  Epidemiology       Date:  2010-01       Impact factor: 4.822

10.  Hypertension in pregnancy as a risk factor for cardiovascular disease later in life.

Authors:  Vesna D Garovic; Kent R Bailey; Eric Boerwinkle; Steven C Hunt; Alan B Weder; David Curb; Thomas H Mosley; Heather J Wiste; Stephen T Turner
Journal:  J Hypertens       Date:  2010-04       Impact factor: 4.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.